This enzyme was cited as a participant in carcinogenesis in several tumors, being overexpressed in BC, especially in luminal and HER2+ subtypes [94] and the plasma membrane of highly invasive cells, including MDA-MB-231 BC cells [95] and GC [96]. Here, ERBB2 is linked to breast cancer.